Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Data shows non-inferiority of SC administration of Roche’s Perjeta and Herceptin

pharmaceutical-technologyDecember 16, 2019

Tag: Roche , Herceptin , Perjeta

PharmaSources Customer Service